{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/bipolar-disorder/goals-outcome-measures/qof-indicators/","result":{"pageContext":{"chapter":{"id":"caccf5a3-718b-556f-a3d7-e412c84fffec","slug":"qof-indicators","fullItemName":"QOF indicators","depth":2,"htmlHeader":"<!-- begin field 3fb65d4c-6cdb-44d8-ad7b-300b0ea12f19 --><h2>QOF indicators</h2><!-- end field 3fb65d4c-6cdb-44d8-ad7b-300b0ea12f19 -->","summary":null,"htmlStringContent":"<!-- begin item 3e0d8c95-2298-4074-a1db-948d04bc258c --><!-- begin field f9b2320d-6abf-4602-a719-9845780edb1b --><p><strong>Table 1. </strong>Indicators related to bipolar disorder in the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract.</p><table data-table-id=\"16847734-79f8-4d4d-8e9f-acce014f5c3c\"><thead><tr><th colspan=\"1\">Indicator</th><th colspan=\"1\">Points</th><th colspan=\"1\">Payment stages</th></tr></thead><tbody><tr><td colspan=\"1\"><strong>MH001.</strong> The contractor establishes and maintains a register of patients with schizophrenia, bipolar affective disorder and other psychoses and other patients on lithium therapy</td><td colspan=\"1\">4</td><td colspan=\"1\">—</td></tr><tr><td colspan=\"1\"><strong>MH002.</strong> The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a comprehensive care plan documented in the record, (in the preceding 12 months) agreed between individuals, their family and/or carers as appropriate</td><td colspan=\"1\">6</td><td colspan=\"1\">40–90%</td></tr><tr><td colspan=\"1\"><strong>MH003.</strong> The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood pressure in the preceding 12 months</td><td colspan=\"1\">4</td><td colspan=\"1\">50–90%</td></tr><tr><td colspan=\"1\"><strong>MH007.</strong> The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of alcohol consumption in the preceding 12 months</td><td colspan=\"1\">4</td><td colspan=\"1\">50–90%</td></tr><tr><td colspan=\"1\"><strong>MH008.</strong> The percentage of women aged 25 or over and who have not attained the age of 65 with schizophrenia, bipolar affective disorder and other psychoses whose notes record that a cervical screening test has been performed in the preceding 5 years</td><td colspan=\"1\">5</td><td colspan=\"1\">45–80%</td></tr><tr><td colspan=\"1\"><strong>MH009.</strong> The percentage of patients on lithium therapy with a record of serum creatinine and TSH in the preceding 9 months</td><td colspan=\"1\">1</td><td colspan=\"1\">50–90%</td></tr><tr><td colspan=\"1\"><strong>MH010.</strong> The percentage of patients on lithium therapy with a record of lithium levels in the therapeutic range in the preceding 4 months</td><td colspan=\"1\">2</td><td colspan=\"1\">50–90%</td></tr><tr><td colspan=\"1\"><strong>SMOK002. </strong>The percentage of patients with schizophrenia, bipolar affective disorder, or other psychoses whose notes record smoking status in the preceding 12 months</td><td colspan=\"1\">25</td><td colspan=\"1\">50–90%</td></tr><tr><td colspan=\"1\"><strong>SMOK003.</strong> The contractor supports patients who smoke in stopping smoking by a strategy which includes providing literature and offering appropriate therapy</td><td colspan=\"1\">2</td><td colspan=\"1\">—</td></tr><tr><td colspan=\"1\"><strong>SMOK004.</strong> The percentage of patients aged 15 or over who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 24 months</td><td colspan=\"1\">12</td><td colspan=\"1\">40–90%</td></tr><tr><td colspan=\"1\"><strong>SMO005K.</strong> The percentage of patients with schizophrenia, bipolar affective disorder or other psychoses who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 12 months</td><td colspan=\"1\">25</td><td colspan=\"1\">56–96%</td></tr><tr><td colspan=\"3\"><strong>Data from: </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bipolar-disorder/references/\">BMA and NHS Employers, 2018</a>]</td></tr></tbody></table><!-- end field f9b2320d-6abf-4602-a719-9845780edb1b --><!-- end item 3e0d8c95-2298-4074-a1db-948d04bc258c -->","topic":{"id":"ac644ce3-3932-5e1f-8676-4ebcfb5f240d","topicId":"87d084eb-bc7f-45b7-9384-f490e6417d9d","topicName":"Bipolar disorder","slug":"bipolar-disorder","lastRevised":"Last revised in February 2021","chapters":[{"id":"3ed6a7a1-589c-57a9-89fd-e61f76a4c198","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"96f8d073-2e2b-55bd-9f94-a0cf336756a7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"5a048129-7c1e-5fc5-8a8a-3e91b2be7e18","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"61d98476-085c-58c4-b646-093d1564a66c","slug":"changes","fullItemName":"Changes"},{"id":"e8e86070-9a3a-5b97-8a3b-d76771dd7e92","slug":"update","fullItemName":"Update"}]},{"id":"308f8462-ca53-5dee-9a6a-463a88283762","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e56ddcf1-8ade-5c55-ada8-cd9307fa9d45","slug":"goals","fullItemName":"Goals"},{"id":"c9a278dc-a960-595c-90fa-702a979fe434","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6c858f7e-b8a9-5125-9b30-d15ff9489c89","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"caccf5a3-718b-556f-a3d7-e412c84fffec","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1d1a32a6-8f9b-54ef-8db8-35685fd71f28","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"31f4b1ea-76e5-5273-821f-7ba3fd77ac0e","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b529213a-3211-53f9-b870-f03b9a1d30c9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"53fd9729-258a-5bc1-ac8d-c7c2ebdfd92e","slug":"definition","fullItemName":"Definition"},{"id":"0dc41761-cd41-54cc-8277-c96320874497","slug":"causes","fullItemName":"Causes"},{"id":"2c7c3452-f7d6-5a4d-ac13-72ecad737a44","slug":"incidence-prevalence","fullItemName":"Incidence and prevalence"},{"id":"7a53a39d-073b-5a29-b48d-a0ff3049049e","slug":"complications","fullItemName":"Complications"},{"id":"ae1afd6c-efdb-5d1f-82a9-ee9a07103bde","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"45d991bb-5121-511b-a201-826c8297a59d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ff54cf2c-7ebb-58b5-a77c-a285db95f263","slug":"suspecting-bipolar-disorder","fullItemName":"Suspecting bipolar disorder"},{"id":"a5cf6d30-ba09-58fa-b2a2-78490ef3dfe6","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"0c45d8c8-9038-5e75-9637-34b9b70a708f","fullItemName":"Management","slug":"management","subChapters":[{"id":"08d1a671-233b-56fe-9343-455ae9d9457c","slug":"primary-care-management","fullItemName":"Scenario: Primary care management"},{"id":"3168933b-1d1b-56e0-82d5-13b7a4175ed1","slug":"managing-relapse","fullItemName":"Scenario: Managing relapse"},{"id":"7fd5675a-5f41-5662-86a1-dcd7103d1e7b","slug":"routine-bipolar-disorder-review","fullItemName":"Scenario: Routine bipolar disorder review"},{"id":"7cd1d695-071f-5e74-945f-e61927a44a85","slug":"women-of-childbearing-age","fullItemName":"Scenario: Women of childbearing age"}]},{"id":"7be9863d-b620-5545-b0ca-d2a5ea14af95","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d0da96ab-51ae-530a-ac52-76b445fb10a5","slug":"ssris","fullItemName":"SSRIs"},{"id":"7ccedc62-ec67-54d4-a721-f520c7573553","slug":"antipsychotics","fullItemName":"Antipsychotics"},{"id":"587e9545-d869-5933-b101-2407ad59bc52","slug":"lamotrigine","fullItemName":"Lamotrigine"},{"id":"f1925178-1888-5bf8-8868-92a526afff0f","slug":"lithium","fullItemName":"Lithium"},{"id":"1933741e-2f27-57bf-92f1-5d769518344f","slug":"valproate","fullItemName":"Valproate"}]},{"id":"1913037b-d494-5a34-be7c-baf4cb96acd4","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"88a92260-20b8-51eb-8b46-3a2409ddf63b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"438d8ad5-e57e-58be-8902-0a3160dc221d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a4449bc7-d64d-5a1c-a07a-b9a548cc3172","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"be352ccd-5a94-556d-b076-f450b54edbfb","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"999ad09a-2f9f-562d-9583-938295801e7f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a2be53e8-c67a-5bbd-a684-a352c46d9902","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c4e156df-5e61-50f0-bcf6-60433f5a4e37","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"308f8462-ca53-5dee-9a6a-463a88283762","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}